New from PharmaprojectsPLUS - 3 new Strategic Reports

Gain essential insight on:

• The Insomnia Market – a concise report on the insomnia market, estimated to be worth over $2.2 billion. This report analyses the dominance of the market leader, Zolpidem, the impact of competition from the “next-generation” drugs and the dramatic changes ahead for the whole insomnia market.

• Next Generation Antibiotics – combating drug resistance – a comprehensive analysis of the antibiotic market with a focus on the "resistance challenge". This report reviews new pharmaceutical classes, individual lead compounds and provides invaluable intelligence for pharmaceutical executives and other interested parties.

• New Drug Targets – a compilation of unique protein targets identified by Pharmaprojects over the past 12 months, giving you access to key R&D data.

Strategic Reports from PharmaprojectsPLUS – giving you extra insight

For further information, please call Andy Freeman on +44 (0) 017 6937, or email andy.freeman@informa.com